title: Technivie for HCV genotype 4 infection.
mesh_terms: D000813:Anilides / Q000008:administration & dosage*; D000818:Animals; D000998:Antiviral Agents / Q000008:administration & dosage; D002219:Carbamates / Q000008:administration & dosage*; D003521:Cyclopropanes; D004338:Drug Combinations; D005838:Genotype; D016174:Hepacivirus / Q000187:drug effects* / Q000235:genetics; D006526:Hepatitis C / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics; D006801:Humans; D047029:Lactams, Macrocyclic; D047028:Macrocyclic Compounds / Q000008:administration & dosage*; D011392:Proline / Q000031:analogs & derivatives; D016032:Randomized Controlled Trials as Topic / Q000379:methods; D019438:Ritonavir / Q000008:administration & dosage*; D013449:Sulfonamides; D014633:Valine
chemical_list: D000813:Anilides; D000998:Antiviral Agents; D002219:Carbamates; D003521:Cyclopropanes; D004338:Drug Combinations; D047029:Lactams, Macrocyclic; D047028:Macrocyclic Compounds; D013449:Sulfonamides; C586094:ombitasvir; D011392:Proline; D014633:Valine; D019438:Ritonavir; C585405:paritaprevir